Lingzhu Gou

机构：Lanzhou University Second Hospital, Lanzhou University · ORCID：0000-0003-2456-3986

发表论文 20 篇 · 总被引 58 次 · h-index 4

代表论文

• Antibiotics Resistance Prevalence of Helicobacter pylori Strains in Northwest China (2022 · Infection and Drug Resistance · 被引 17)
• High‐dose amoxicillin‐proton pump inhibitor dual therapy as first‐line treatment for Helicobacter pylori infection in Northwest China: A prospective, randomised controlled trial (2022 · British Journal of Clinical Pharmacology · 被引 13)
• Roles of the components of the cag -pathogenicity island encoded type IV secretion system in Helicobacter pylori (2024 · Future Microbiology · 被引 8)
• Application value and performance of stool antigen detection in the diagnosis of Helicobacter pylori infection (2025 · European Journal of Clinical Microbiology & Infectious Diseases · 被引 5)
• New Directions in Helicobacter pylori Urease Inhibitors: Focusing on Nickel Ions Transfer and Auxiliary Protein Interactions During Urease Maturation (2025 · Infection and Drug Resistance · 被引 4)
• Antimicrobial drug susceptibility testing for the management of Helicobacter pylori infection in personalized eradication therapy (2025 · Frontiers in Microbiology · 被引 3)